Related Experiment Video
Updated: Feb 6, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
The ImproveCareNow registry: Prediction of 2-year nonremission in pediatric ulcerative colitis
Jonathan Van Hecke1, Gigi Veereman2, Koen Huysentruyt2
1Geneeskunde en Farmacie, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Insights
Predictors of unfavorable pediatric ulcerative colitis (UC) course include higher disease severity and BMI z-score, and not using immunomodulators (IM) early on. These factors may guide early treatment strategies for UC patients.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Clinical Epidemiology
Background:
- Pediatric ulcerative colitis (UC) poses challenges in predicting disease course.
- Identifying early predictors of unfavorable outcomes is crucial for timely therapeutic intervention.
Purpose of the Study:
- To define predictors of nonremission at 2 years post-diagnosis in pediatric UC patients.
- To inform therapeutic strategies by identifying early indicators of disease severity.
Main Methods:
- Retrospective analysis of prospectively collected data from ImproveCareNow (2007-2023).
- Included 1290 pediatric UC patients (<18 years) with ≥2-year follow-up.
- Used logistic regression to identify predictors of nonremission, defining remission as pediatric UC activity index (PUCAI) <10.
Main Results:
- 30% of patients (390/1290) were not in remission at 2 years.
- Higher PUCAI scores (mild, moderate, severe), increased BMI z-score, and non-use of immunomodulators (IM) at T1 predicted non-remission at T2.
- Predictive ability was limited (AUC 0.599-0.621).
Conclusions:
- Increasing disease severity (PUCAI), higher BMI z-score, and lack of early IM use are predictors of an unfavorable pediatric UC course.
- These findings may guide therapeutic decisions shortly after diagnosis.
- Further research may refine predictive models for pediatric UC.
Objective:
Identifying predictors of unfavorable disease course in pediatric ulcerative colitis (UC) will impact therapeutic strategy. We aimed to define predictors of nonremission 2 years after diagnosis in pediatric patients with UC.
Methods:
This retrospective analysis of prospectively collected data from ImproveCareNow included pediatric UC patients (<18 years) diagnosed between 2007 and 2023 with at least a 2-year follow-up. Remission was defined as a pediatric UC activity index (PUCAI) < 10 points. Statistical analysis was performed using the International Business Machines Corporation Statistical Package for the Social Sciences (SPSS) version 29. Demographic information at diagnosis/enrollment (T0), first visit (T1) and follow-up (T2, closest to 24 months) were calculated between relevant groups. Binary logistic regression was used to identify outcome predictors. Multiple imputation was used for missing data. This study was approved by the Ethics Committee (Protocol 23135-ICN_UC).
Results:
We included 1290 pediatric UC patients. Two years after diagnosis, 390 patients (30%) were not in remission at T2. Differences in disease severity and treatment were observed at T1 and T2. PUCAI (mild odds ratio [OR] = 1.946, moderate OR = 1.735, or severe disease OR = 3.183, p < 0.01), the use of immunomodulators (IM) (OR = 0.631, p = 0.053) and body mass Index (BMI) z-score (OR = 1.149, p = 0.022) at T1 (mean 30 days) predicted non-remission at T2 with poor discriminating ability (area under the curve 0.599-0.621).
Conclusion:
Predictors for unfavorable disease course were increasing disease severity according to PUCAI (vs. inactive disease), increasing BMI z-score (per z-score increase) and nonuse of IM at T1. These predictors may impact therapeutic strategy shortly after diagnosis.
More Related Videos
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Predicting Products: SN1 vs. SN2
With increased substitution on the alkyl halide,...
Predicting Molecular Geometry
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.